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In September 2004, Italy's health minister, Girolamo Sirchia, hailed the successful treatment of a five-year-old boy with thalassaemia, an inherited form of life-threatening anaemia. The therapy involved transplanting stem cells of the umbilical cord blood of the boy's newborn twin siblings. The minister hoped to use this case to convince the Italian public of the potential of non-embryo-derived stem cells and to justify the contentious Italian law on assisted reproduction. However, soon after his 'triumph' it became known that the twin pregnancy was realised with IVF and the selection of embryos through PGD and HLA typing, in a hospital in Turkey, techniques which Sirchia considers as immoral and which are outlawed by the Italian government.
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Promises of stem cell research
Stem cells hold great promise for medicine. Because of their proliferation and differentiation capacities they are widely believed to represent the greatest promise for medicine in the twenty-first century. They could be used to treat a variety of diseases and conditions, including diabetes, Parkinson's disease, heart disease, spinal cord injuries, blindness, deafness and many types of cancer. Unlike current drugs, which mainly delay symptoms of diseases, stem cells may make it possible to replace damaged tissue or even whole organs. Their value extends beyond utility in cell therapy. Stem cells are also useful tools for fundamental research, mainly for gaining knowledge about early human development, cell division and differentiation mechanisms, gene and protein function, for developing drugs and toxicity testing, and for developing models of human diseases.
3 This immense promise gives powerful moral reasons for pursuing stem cell research. At present there are three main lines of stem cell research:
4 on stem cells originating from early in vitro embryos made available as surplus to those required for infertility treatments or especially created for research through IVF or nuclear transfer (embryonic stem cells); on cord blood-derived stem cells; and on stem cells originating from tissues or organs from foetuses or organisms after birth (adult stem cells). There is a growing consensus among scientists worldwide that all these lines of research are promising. Embryonic, cord blood and adult stem cells may have different qualities and might be useful for different purposes. In some cases the best option may be combined adult and embryonic stem cell therapy.
5 So rather than opting for one line of research, the ideal research strategy to reach the intended research goals would be to proceed with research on all types of stem cells.
However, embryonic stem cell research which involves the destruction of the embryo is opposed by those who regard the embryo as in some important sense 'one of us'. In the opinion of those who take this view, the embryo should never be used as a mere means, even if this could save millions of lives.
6 They advocate the legal prohibition of stem cell research or therapy that involves 'the killing' of human embryos. This approach may be summed up in the phrase 'the embryo is one of us', which entered the vocabulary of the moral status of the embryo via a leading Italian Catholic commentator. It has since become associated with this debate not only in the Italian context but more generally.
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Stem cell policy
The fact that there are no cures as yet on the basis of embryonic stem cells (ES cells) can appear as an embarrassment for those seeking clear justification of ES cell research. This creates a situation in which tensions between ethics and politics are unavoidable and very visible. An argument that always surfaces in the stem cell debate, and about which there is a broad consensus, is that there is no need to permit more ethically contentious ways of generating stem cell lines, if the same benefits can be realised using less contentious stem cells.
8 It is sometimes referred to as the principle of subsidiarity 9 and it is closely bound up with the principles of proportionality and necessity, which require that any action should not go beyond what is necessary to achieve the objectives. The principle is referred to very often in reports and recommendations on stem cell research. The Belgian law on the Protection of the Embryo in Vitro, for example, states in Art.3 §6 that research on
